Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Tamás Kőszegi:

Flow cytometry in rapid mycotoxin testing. Kőszegi T et al. Cytometry A. (2017)

Plasma Actin, Gelsolin and Orosomucoid Levels after Eccentric Exercise. Tékus É et al. J Hum Kinet. (2017)

Angiotensin-converting Enzyme Inhibition Improves the Effectiveness of Transcutaneous Carbon Dioxide Treatment. Nemeth B et al. In Vivo. (2017)

Search results

Items: 1 to 20 of 62

1.

Antioxidant and antimicrobial properties of randomly methylated β cyclodextrin - captured essential oils.

Das S, Gazdag Z, Szente L, Meggyes M, Horváth G, Lemli B, Kunsági-Máté S, Kuzma M, Kőszegi T.

Food Chem. 2019 Apr 25;278:305-313. doi: 10.1016/j.foodchem.2018.11.047. Epub 2018 Nov 9.

PMID:
30583377
2.

Serum and follicular fluid levels of sirtuin 1, sirtuin 6, and resveratrol in women undergoing in vitro fertilization: an observational, clinical study.

Bódis J, Sulyok E, Kőszegi T, Gödöny K, Prémusz V, Várnagy Á.

J Int Med Res. 2019 Feb;47(2):772-782. doi: 10.1177/0300060518811228. Epub 2018 Dec 16.

3.

Elevated urinary orosomucoid excretion as a novel biomarker in Crohn's disease.

Szirmay B, Tárnok A, Sarlós P, Szigeti N, Ludány A, Kustán P, Horváth-Szalai Z, Miseta A, Kőszegi T.

Eur J Clin Invest. 2019 Mar;49(3):e13054. doi: 10.1111/eci.13054. Epub 2018 Dec 13.

PMID:
30451301
4.

Interaction of the mycotoxin metabolite dihydrocitrinone with serum albumin.

Faisal Z, Vörös V, Lemli B, Derdák D, Kunsági-Máté S, Bálint M, Hetényi C, Csepregi R, Kőszegi T, Bergmann D, Sueck F, Humpf HU, Hübner F, Poór M.

Mycotoxin Res. 2019 May;35(2):129-139. doi: 10.1007/s12550-018-0336-z. Epub 2018 Nov 13.

PMID:
30426325
5.

Levels of total antioxidant capacity and 8-hydroxy-2'-deoxyguanosine of serum and follicular fluid in women undergoing in vitro fertilization: focusing on endometriosis.

Várnagy Á, Kőszegi T, Györgyi E, Szegedi S, Sulyok E, Prémusz V, Bódis J.

Hum Fertil (Camb). 2018 Nov 13:1-9. doi: 10.1080/14647273.2018.1535719. [Epub ahead of print]

PMID:
30422732
6.

Microchip gel electrophoretic analysis of perchloric acid-soluble serum proteins in systemic inflammatory disorders.

Makszin L, Kustán P, Szirmay B, Páger C, Mező E, Kalács KI, Pászthy V, Györgyi E, Kilár F, Ludány A, Kőszegi T.

Electrophoresis. 2019 Feb;40(3):447-454. doi: 10.1002/elps.201800378. Epub 2018 Nov 16.

PMID:
30407655
7.

A One-Step Extraction and Luminescence Assay for Quantifying Glucose and ATP Levels in Cultured HepG2 Cells.

Csepregi R, Temesfői V, Sali N, Poór M, W Needs P, A Kroon P, Kőszegi T.

Int J Mol Sci. 2018 Sep 8;19(9). pii: E2670. doi: 10.3390/ijms19092670.

8.

Interaction of 2'R-ochratoxin A with Serum Albumins: Binding Site, Effects of Site Markers, Thermodynamics, Species Differences of Albumin-binding, and Influence of Albumin on Its Toxicity in MDCK Cells.

Faisal Z, Derdák D, Lemli B, Kunsági-Máté S, Bálint M, Hetényi C, Csepregi R, Kőszegi T, Sueck F, Cramer B, Humpf HU, Poór M.

Toxins (Basel). 2018 Sep 1;10(9). pii: E353. doi: 10.3390/toxins10090353.

9.

Urinary Orosomucoid A Potential Marker Of Inflammation In Psoriasis.

Kustán P, Kőszegi T, Miseta A, Péter I, Ajtay Z, Kiss I, Németh B.

Int J Med Sci. 2018 Jul 13;15(11):1113-1117. doi: 10.7150/ijms.25687. eCollection 2018.

10.

Carboxamido steroids inhibit the opening properties of transient receptor potential ion channels by lipid raft modulation.

Sághy É, Payrits M, Bíró-Sütő T, Skoda-Földes R, Szánti-Pintér E, Erostyák J, Makkai G, Sétáló G Jr, Kollár L, Kőszegi T, Csepregi R, Szolcsányi J, Helyes Z, Szőke É.

J Lipid Res. 2018 Oct;59(10):1851-1863. doi: 10.1194/jlr.M084723. Epub 2018 Aug 9.

11.

Green Fluorescent Protein-Based Viability Assay in a Multiparametric Configuration.

Csepregi R, Temesfői V, Poór M, Faust Z, Kőszegi T.

Molecules. 2018 Jun 28;23(7). pii: E1575. doi: 10.3390/molecules23071575.

12.

Novel automated immune turbidimetric assay for routine urinary cystatin-C determinations.

Szirmay B, Kustán P, Horváth-Szalai Z, Ludány A, Lakatos Á, Mühl D, Wittmann I, Miseta A, Kovács GL, Kőszegi T.

Bioanalysis. 2018 Mar 1;10(6):377-384. doi: 10.4155/bio-2017-0228. Epub 2018 Feb 16.

13.

Complex Formation of Resorufin and Resazurin with Β-Cyclodextrins: Can Cyclodextrins Interfere with a Resazurin Cell Viability Assay?

Csepregi R, Lemli B, Kunsági-Máté S, Szente L, Kőszegi T, Németi B, Poór M.

Molecules. 2018 Feb 10;23(2). pii: E382. doi: 10.3390/molecules23020382.

14.

Predictive value of serum gelsolin and Gc globulin in sepsis - a pilot study.

Horváth-Szalai Z, Kustán P, Szirmay B, Lakatos Á, Christensen PH, Huber T, Bugyi B, Mühl D, Ludány A, Miseta A, Kovács GL, Kőszegi T.

Clin Chem Lab Med. 2018 Jul 26;56(8):1373-1382. doi: 10.1515/cclm-2017-0782.

PMID:
29320362
15.

Investigation of Non-Covalent Interactions of Aflatoxins (B1, B2, G1, G2, and M1) with Serum Albumin.

Poór M, Bálint M, Hetényi C, Gődér B, Kunsági-Máté S, Kőszegi T, Lemli B.

Toxins (Basel). 2017 Oct 25;9(11). pii: E339. doi: 10.3390/toxins9110339.

16.

A novel luminol-based enhanced chemiluminescence antioxidant capacity microplate assay for use in different biological matrices.

Kőszegi T, Sali N, Raknić M, Horváth-Szalai Z, Csepregi R, Končić MZ, Papp N, Poór M.

J Pharmacol Toxicol Methods. 2017 Nov - Dec;88(Pt 2):153-159. doi: 10.1016/j.vascn.2017.09.256. Epub 2017 Sep 28.

PMID:
28962917
17.

Validation of an automated immune turbidimetric assay for serum gelsolin and its possible clinical utility in sepsis.

Horváth-Szalai Z, Kustán P, Szirmay B, Lakatos Á, Christensen PH, Huber T, Bugyi B, Mühl D, Ludány A, Miseta A, Kovács GL, Kőszegi T.

J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22321. Epub 2017 Sep 5.

PMID:
28872708
18.

Monitoring urinary orosomucoid in patients undergoing cardiac surgery: A promising novel inflammatory marker.

Kustán P, Szirmay B, Kőszegi T, Ludány A, Kovács GL, Miseta A, Mühl D, Németh B, Kiss I, Németh Á, Szabados S, Ajtay Z.

Clin Biochem. 2017 Dec;50(18):1002-1006. doi: 10.1016/j.clinbiochem.2017.07.010. Epub 2017 Jul 21.

PMID:
28736055
19.

Plasma Actin, Gelsolin and Orosomucoid Levels after Eccentric Exercise.

Tékus É, Váczi M, Horváth-Szalai Z, Ludány A, Kőszegi T, Wilhelm M.

J Hum Kinet. 2017 Mar 15;56:99-108. doi: 10.1515/hukin-2017-0027. eCollection 2017 Feb.

20.

Angiotensin-converting Enzyme Inhibition Improves the Effectiveness of Transcutaneous Carbon Dioxide Treatment.

Nemeth B, Kiss I, Jencsik T, Peter I, Kreska Z, Koszegi T, Miseta A, Kustan P, Boncz I, Laczo A, Ajtay Z.

In Vivo. 2017 May-Jun;31(3):425-428.

Supplemental Content

Loading ...
Support Center